CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
How a Health Care Supply Chain Officer Supports Patient Care
The Transforming Power of Sickle Cell Gene Therapy (and Why Access Is Important)
Children’s Hospitals Call on Congress to Confront Alarming Rise in Youth Suicide
How a Health Care Supply Chain Officer Supports Patient Care
Discover insights from a longtime children’s hospital supply chain leader on supporting patient care, community needs, and the health care supply chain.
Sep. 16, 2025
The Transforming Power of Sickle Cell Gene Therapy (and Why Access Is Important)
A revolutionary therapy takes some children’s lives to new heights. Others are left out.
Sep. 12, 2025
Children’s Hospitals Call on Congress to Confront Alarming Rise in Youth Suicide
As National Suicide Prevention Month begins, Children’s Hospital Association urges lawmakers to expand access to pediatric mental health care and prevention programs.
Sep. 11, 2025
